241 related articles for article (PubMed ID: 29949785)
1. Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
Wang J; Fang R; Wang L; Chen G; Wang H; Wang Z; Zhao D; Pavlov VN; Kabirov I; Wang Z; Guo P; Peng L; Xu W
Cell Physiol Biochem; 2018; 47(4):1565-1577. PubMed ID: 29949785
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
[TBL] [Abstract][Full Text] [Related]
5. New optical imaging technologies for bladder cancer: considerations and perspectives.
Liu JJ; Droller MJ; Liao JC
J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
8. Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers.
Malentacchi F; Vinci S; Melina AD; Kuncova J; Villari D; Nesi G; Selli C; Orlando C; Pazzagli M; Pinzani P
Urol Oncol; 2016 Jul; 34(7):292.e9-292.e16. PubMed ID: 27005925
[TBL] [Abstract][Full Text] [Related]
9. Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments.
Malentacchi F; Vinci S; Della Melina A; Kuncova J; Villari D; Giannarini G; Nesi G; Selli C; Orlando C
Urol Oncol; 2012; 30(3):278-84. PubMed ID: 20875751
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy.
Huang W; Wang K; Huang W; He Z; Zhang J; Zhang B; Xiong Z; Gillen KM; Li W; Chen F; Yang X; Zhang S; Tian J
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4427-4439. PubMed ID: 35925443
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic molecular imaging of human bladder cancer using a CD47 antibody.
Pan Y; Volkmer JP; Mach KE; Rouse RV; Liu JJ; Sahoo D; Chang TC; Metzner TJ; Kang L; van de Rijn M; Skinner EC; Gambhir SS; Weissman IL; Liao JC
Sci Transl Med; 2014 Oct; 6(260):260ra148. PubMed ID: 25355698
[TBL] [Abstract][Full Text] [Related]
12. Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma.
Young JR; Coy H; Kim HJ; Douek M; Sisk A; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2018 Dec; 211(6):1254-1258. PubMed ID: 30300009
[TBL] [Abstract][Full Text] [Related]
13. Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs.
Zhu L; Guo Y; Wang L; Fan X; Xiong X; Fang K; Xu D
J Nanobiotechnology; 2017 Sep; 15(1):63. PubMed ID: 28962657
[TBL] [Abstract][Full Text] [Related]
14. Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX.
Garousi J; Honarvar H; Andersson KG; Mitran B; Orlova A; Buijs J; Löfblom J; Frejd FY; Tolmachev V
Mol Pharm; 2016 Nov; 13(11):3676-3687. PubMed ID: 27529191
[TBL] [Abstract][Full Text] [Related]
15. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.
Hoskin PJ; Sibtain A; Daley FM; Wilson GD
Br J Cancer; 2003 Oct; 89(7):1290-7. PubMed ID: 14520462
[TBL] [Abstract][Full Text] [Related]
16. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Carbonic Anhydrase IX is a Dismal Prognostic Marker in Breast Carcinoma in Egyptian Patients.
Samaka RM; Abd El-Wahed MM; Al Sharaky DR; Shehata MA; Hegazy SE; Aleskandarany MA
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):405-13. PubMed ID: 26574633
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts.
Garousi J; Huizing FJ; Vorobyeva A; Mitran B; Andersson KG; Leitao CD; Frejd FY; Löfblom J; Bussink J; Orlova A; Heskamp S; Tolmachev V
Sci Rep; 2019 Oct; 9(1):14907. PubMed ID: 31624303
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.
van Brussel AS; Adams A; Oliveira S; Dorresteijn B; El Khattabi M; Vermeulen JF; van der Wall E; Mali WP; Derksen PW; van Diest PJ; van Bergen En Henegouwen PM
Mol Imaging Biol; 2016 Aug; 18(4):535-44. PubMed ID: 26589824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
